刘志霞+陈劲智+黄梅华

【摘要】 目的：研究乳腺癌新輔助化疗实施护理风险管理的价值。方法：选择笔者所在医院2015年1月-2016年3月收治的83例乳腺癌新辅助化疗患者为研究对象。采用简单随机化法将83例患者分为常规组和风险管理组。常规组进行乳腺癌新辅助化疗常规护理；风险管理组在常规组基础上实施护理风险管理。观察比较两组护理管理满意度，静脉炎、局部坏死、药物外渗、骨髓抑制等并发症发生情况，患者护理质量评分、住院时间。结果：（1）风险管理组护理管理满意度高于常规组，差异有统计学意义（P<0.05）；（2）风险管理组静脉炎、局部坏死、药物外渗、骨髓抑制等并发症总发生率低于常规组，差异有统计学意义（P<0.05）；（3）风险管理组护理质量评分高于常规组，住院时间短于常规组，差异均有统计学意义（P<0.05）。结论：乳腺癌新辅助化疗实施护理风险管理的价值高，可有效规避静脉炎、局部坏死等风险的发生，提高护理质量，缩短住院时间，患者满意度高，值得推广。

【关键词】 乳腺癌新辅助化疗； 护理风险管理； 价值评估

doi：10.14033/j.cnki.cfmr.2016.33.029 文献标识码 B 文章编号 1674-6805（2016）33-0058-03

【Abstract】 Objective：To study the value of nursing risk management in the implementation of neoadjuvant chemotherapy for breast cance.Method：83 cases of breast cancer patients with neoadjuvant chemotherapy in our hospital from January 2015 to March 2016 were selected and randomly divided into the routine group and the risk management group according to simple randomization method.The routine group was given routine nursing care of new adjuvant chemotherapy for breast cancer.The risk management group was given implementation of nursing risk management on the basis of the conventional group.The nursing management satisfaction，the incidence of complications of phlebitis，local necrosis，drug extravasation and bone marrow suppression，patients care quality score，the hospitalization time were observed and compared between the two groups.Result：（1）The nursing management satisfaction of the risk management group was higher than that of the routine group，the difference was statistically significant（P<0.05）.（2）The total incidence rate of complications of phlebitis，local necrosis，drug extravasation and bone marrow suppression in the risk management group was lower than that of the routine group，the difference was statistically significant（P<0.05）.（3）The nursing care quality score of the risk management group was higher than that of the routine group，the hospitalization time of the risk management group was shorter than that of the routine group，the differences were statistically significant（P<0.05）.Conclusion：Implementing nursing risk management in neoadjuvant chemotherapy for breast cancer has high value，which can effectively avoid the occurrence of phlebitis，local necrosis of risk，improve nursing quality，shorten the hospitalization time，improve patients satisfaction，it is worthy of promotion.

【Key words】 Neoadjuvant chemotherapy of breast cancer； Nursing risk management； Value evaluation

First-authors address：Quanzhou Hospital of Traditional Chinese Medicine，Quanzhou 362000，China

乳腺癌为妇科常见恶性肿瘤，其发病率高，在40～60岁女性中高发，对女性健康造成严重威胁。目前，临床对乳腺癌的治疗多建议采取手术根治治疗，但术后多需通过化疗抑制病情进展，以延长患者生存期，提高其生存率。但化疗药物毒副作用较多，可带来严重并发症，加上术后化疗疗程长，化疗过程护理风险发生率高，均不利于化疗效果的提高，需强化风险管理[1]。本研究对乳腺癌新辅助化疗实施护理风险管理的价值进行分析，报告如下。

1 资料与方法

1.1 一般资料

选择笔者所在医院2015年1月-2016年3月收治的83例乳腺癌新辅助化疗患者为研究对象。采用简单随机化法将83例患者分为常规组和风险管理组。风险管理组42例患者：年龄28～62岁，平均（45.34±3.29）岁；TNM分期：1期23例，

2期10例，3期9例。常规组41例患者：年龄27～62岁，平均（45.55±3.32）岁。……